NEW YORK (GenomeWeb) – The Scripps Research Institute (TSRI) announced today that it has partnered with Pfizer to develop a novel chemical synthesis technology for creating next-generation DNA-encoded libraries (DELs).

Under the terms of the deal, Pfizer will pay an undisclosed fee to gain access to a chemical synthesis technology developed at TSRI. The two will adapt this technology for use in creating DELs, and choose to expand their joint research to include other technologies enabling DEL-based drug discovery.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.